
"2024: The Year of Revolutionary Weight-Loss Treatments and Healthcare Shifts"
The US health care system is poised for significant changes in 2024, with the potential CRISPR revolution and a new approach to drug pricing that could reshape the industry. Innovations include effective weight-loss drugs and a growing acceptance of psychedelics like MDMA for PTSD and esketamine for depression, with MDMA showing promising trial results. Additionally, 2024 will introduce new price limits on drugs covered by Medicare, signaling a shift in how drug costs are managed.
